A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

Inclusion Criteria

• •1. Male and female adults aged 19 years or older
• •2. Blood pressure: Mean blood pressure is as below at screening.
• •* For treatment-naïve patients: 140 mmHg ≤ SBP \< 180 mmHg and DBP \< 110 mmHg
• •* For patients who are taking ACEI or ARB: 130 mmHg ≤ SBP \< 180 mmHg and DBP \< 110 mmHg
• •3. eGFR: ≥ 30 ml/min/1.73 m2 within the past 6 months
• •4. Albuminuria (ACR) excretion volume: Meets one or more of the following conditions
• •* ACR \> 300 mg/g (or mg/day) within the past 12 months
• •* There are at least two results of 30 ≤ ACR ≤ 300 mg/g (or mg/day) within the past 12 months and the interval between the two test is at least 12 weeks.
• •5. Patients with diabetes
• •6. Voluntarily provided a written consent to participate
• •7. Able to understand this study, be cooperative in the execution of the study